CCND1 and breast cancer: Cyclin D1 has been reported for a long time as an E2 target in breast cancer cells [41,43,44] which plays a key function in the hormone-dependent promotion of G1/S transition, as confirmed by the increase in cells in the S phase after hormone treatment.